Nachrichten zur Merck & Co. Inc. Aktie

Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal

Merck will pay Hansoh $112 million upfront for rights to the drug, with the potential for an additional $1.9 billion…

Merck & Co Aktie: Der Pharma-Riese sucht Wachstum - Hansoh-Deal als Vorgeschmack auf größere Übernahmen?

Kulmbach (www.aktiencheck.de) - Merck & Co-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt die Aktie von Merck &…

Merck pens $2bn deal for obesity drug from China’s Hansoh

Merck & Co Inc (NYSE:MRK, ETR:6MK) has sought a potential weight loss drug candidate through a deal worth up to…

3 No-Brainer Biotech Stocks to Buy With $200 Right Now

Investing in biotech stocks usually isnt for the faint of heart. These stocks tend to be highly volatile because of…

DAX vor Fed-Entscheid leichter – Ceconomy, Commerzbank, Daimler Truck, Infineon, Kontron, Mercedes-Benz, Merck, MTU, Pro7, Redcare im Check

Vor der wichtigen Notenbanksitzung heute Abend halten sich die deutschen Anleger zurück. Der DAX hat den Handel am Dienstag bei…

DAX vor Fed-Entscheid leichter – Ceconomy, Commerzbank, Daimler Truck, Infineon, Kontron, Mercedes-Benz, Merck, MTU, Pro7, Redcare im Check

Vor der wichtigen Notenbanksitzung heute Abend halten sich die deutschen Anleger zurück. Der DAX hat den Handel am Dienstag bei…

Mercks BLA for RSV Antibody Clesrovimab Gets FDA Acceptance

The FDA accepts MRKs BLA for clesrovimab, its monoclonal antibody, to protect infants from RSV disease. A decision from the…

Merck übernimmt Spezialisten für Zellkulturmodelle

DARMSTADT (dpa-AFX) - Der Darmstädter Pharma- und Technologiekonzern Merck stärkt sein Geschäft mit einer weiteren Übernahme. Der Dax -Konzern…

Merck übernimmt Spezialisten für Zellkulturmodelle

DARMSTADT (dpa-AFX) - Der Darmstädter Pharma- und Technologiekonzern Merck stärkt sein Geschäft mit einer weiteren Übernahme. Der DAX-Konzern kauft das…

Merck: Buy Opportunity Backed By Growth

…

Merck ends development of two antibody programs

…

Merck Has Become Very Cheap Again

…

2 Soaring Stocks That Could Climb 68% to 166% Higher in 2025, According to Wall Street

Its been a good year for the stock market as a whole and a tremendous year for a couple of…

Investing $5,000 in Each of These 3 Stocks at the Start of 2024 Would Have Created a Portfolio Worth More Than $100,000 Today

Normally, you might expect to achieve significant gains from stocks if you invest in them for years, perhaps decades. But…

Merck gets positive EU regulatory opinion for Welireg

…

These Are the 5 Worst-Performing Stocks in the Dow Jones Industrial Average With 2024 Almost Over

Its been a banner year for the stock market. However, not every stock has been a winner as some sectors…

Prediction: This Stock Will Beat the Market in 2025

It hasnt been a great year for Iovance Biotherapeutics (NASDAQ: IOVA), an innovative mid-cap biotech company. The drugmakers shares have…

Merck & Co Aktie: Wiederaufnahme der Coverage

Charlotte (www.aktiencheck.de) - Rating-Upgrade: Die Analysten von BofA Securities nehmen die Coverage der Aktie von Merck & Co Inc. (ISIN: US58933Y1055,…

Top Analyst Reports for Alphabet, Oracle & Merck

Todays Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), Oracle Corporation (ORCL) and Merck…

MRKs Keytruda & Lynparza Combo Meets Goal in Ovarian Cancer Study

The KEYLYNK-001 study evaluating Mercks Keytruda plus chemotherapy followed by maintenance with Lynparza meets the primary goal in epithelial ovarian…

While This High-Yield Dividend ETF Holds 75 Stocks, Its Top 2 Comprise 16.5% of Its Total Holdings

iShares Core High Dividend ETF (NYSEMKT: HDV) is a popular exchange-traded fund (ETF) among those seeking to generate passive income.…

2 Healthcare Dividend Stocks to Hold for the Long Haul

Investors looking for stocks to hold on to for a while might want to consider dividend-paying companies. Besides offering a…

Why Summit Therapeutics Stock Rocketed 6% Higher on Friday

Summit Therapeutics (NASDAQ: SMMT) stock got a real shot in the arm Friday with the initiation of coverage by a…

Is Now the Time to Buy 3 of the S&P 500s Worst-Performing Stocks of 2024?

The S&P 500 has hit record levels this year and many stocks have generated fantastic returns for investors. But theres…

Merck Aktie: Solide Zahlen, verhaltener Ausblick

Schwarzach am Main (www.aktiencheck.de) - Merck Aktie: Solide Zahlen, verhaltener Ausblick Der Pharma- und Technologiekonzern Merck (ISIN: DE0006599905, WKN: 659990, Ticker-Symbol:…

3 Ultra-Cheap Dividend Stocks to Buy in December

If youre concerned about rising valuations in the stock market or just want some reliable income for your portfolio, now…

HSBC upgrades Merck stock to Buy on 2025 opportunities By Investing.com

HSBC upgrades Merck stock to Buy on 2025 opportunities…

Merck & Co Aktie: Für langfristige Investoren attraktiv

London (www.aktiencheck.de) - Merck & Co-Aktienanalyse von HSBC: 1. Hintergrund und Kontext HSBC hat die Aktie von Merck & Co Inc. (ISIN:…

Mercks ADC Drug Gets FDA Breakthrough Therapy Tag in NSCLC

This is the first breakthrough therapy designation granted to MRKs sacituzumab tirumotecan in the United States.…

Merck & Co., Inc. (MRK) 7th Annual Evercore ISI HealthCONx Conference (Transcript)

…

09:58: Merck: Q3 besser als erwartet, Aktie gibt nach

Bei Merck (DE0006599905) klingeln wieder die Kassen: Der Darmstädter Technologie- und Pharmakonzern konnte das Ergebnis im dritten Quartal unerwartet deutlich…

JPMorgan belässt Merck KGaA auf Overweight - Ziel 190 Euro

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Merck KGaA mit einem Kursziel von 190 Euro auf "Overweight" belassen.…

Merck Kaufen

FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat den fairen Wert für Merck KGaA von 205 auf 201 Euro gesenkt,…

DZ Bank senkt fairen Wert für Merck KGaA auf 201 Euro - Kaufen

FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat den fairen Wert für Merck KGaA von 205 auf 201 Euro gesenkt,…

Merck Aktie: Kursziel gesenkt

New York (www.aktiencheck.de) - Rating-Update: Die Analysten von Morgan Stanley stufen die Aktie der Merck KGaA (ISIN: DE0006599905, WKN: 659990, Ticker-Symbol:…

Merck Stock Up as Winrevair Meets Goal in Advanced PAH Study

MRKs study of PAH drug Winrevair in a more advanced form of the disease shows overwhelming efficacy.…

Bath & Body Works, Palantir and Merck rise premarket, Macys falls By Investing.com

Bath & Body Works, Palantir and Merck rise premarket, Macys falls…

Mercks therapy for rare lung condition shown to help reduce risk of death in study By Reuters

Mercks therapy for rare lung condition shown to help reduce risk of death in study…

Merck Aktie: 196 oder 180 Euro? Alle Kursziele und Ratings der Analysten nach Q3-Zahlen auf einen Blick

Darmstadt (www.aktiencheck.de) - Welche Kursziele und Ratings trauen die Analysten der führenden Banken und Research-Häuser der Merck-Aktie (ISIN: DE0006599905, WKN:…

3 Monster Stocks in the Making

Godzilla and King Kong surely werent born big. They began small and grew over time to their gargantuan sizes even…

Leichte Zugewinne bei der Merck & Co-Aktie (97,4751 €)

Im US-amerikanischen Wertpapierhandel liegt das Wertpapier von Merck & Co gegenwärtig im Plus. Das Wertpapier kostete zuletzt 101,34 US-Dollar. Für…

The Zacks Analyst Blog Highlights Broadcom, Merck, Qualcomm and Natural Health

Broadcom, Merck, Qualcomm and Natural Health are included in this Analyst Blog.…

Merck & Co., Inc. (MRK) Jefferies London Healthcare Conference

…

2 Beaten-Down Healthcare Stocks to Buy Hand Over Fist

Every company faces challenges. Sometimes, those issues are deeply damaging to a corporations investment thesis. Other times, though, thats not…

These Are the 5 Worst-Performing Stocks in the Dow Jones Industrial Average With 2024 Almost Over

The Dow Jones Industrial Average (DJINDICES: ^DJI) is enjoying a nice year. The venerable stock market index has risen more…

Merck & Co Aktie: Subkutanes Keytruda erzielt wichtigen Erfolg in Phase-3-Studie

New York (www.aktiencheck.de) - Merck & Co-Aktienanalyse von Jefferies & Co: Rating und Kursziel Jefferies hat das Kursziel für Merck & Co…

Merck: Seriously Undervalued At Peak Pessimism (Rating Upgrade)

…

Merck Among 10 Companies To Announce Annual Dividend Increases In Second Half Of November

…

JPMorgan belässt Merck KGaA auf Overweight - Ziel 190 Euro

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Merck KGaA mit einem Kursziel von 190 Euro…

Merck Gets Positive CHMP Opinion for Keytruda in Mesothelioma

The CHMP renders a positive opinion recommending approval for MRKs Keytruda for the first-line treatment of malignant pleural mesothelioma.…